Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s): KHRNF | KHRWF | V.KHRN.WT.H

Healthcare Cannabis

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.

TSXV:KHRN.H - Post by User

Khiron Life Sciences Corp > Khiron Life Sciences Reports 2019 Fiscal Year End Results

<< Previous

Bullboard Posts

Next >>

Comment by Liscomorris1on May 06, 2020 8:44am

265 Views

Post# 30991829

RE:RE:RE:Khiron Life Sciences Reports 2019 Fiscal Year End Results

its my belief that the major infrastructure and network investment has peaked and has bear some very good fruit with all of the contracts and relationships theyve established. Burn rate will most certainly go down like a covid 19 flattening of the curve. Add the increase in revenues that they are already beginning to see in Q12020 and we will see KHRN turn to positive cash flow within 12 months. All IMO. GLTA

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec